United Arab Emirates
· Delayed Price · Currency is AED JULPHAR Statistics
Total Valuation
Gulf Pharmaceutical Industries P.S.C. has a market cap or net worth of AED 1.06 billion. The enterprise value is 1.96 billion.
| Market Cap | 1.06B |
| Enterprise Value | 1.96B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Gulf Pharmaceutical Industries P.S.C. has 1.16 billion shares outstanding.
| Shares Outstanding | 1.16B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 23.76% |
| Owned by Institutions (%) | 0.17% |
| Float | 355.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.64 |
| PB Ratio | 1.37 |
| P/FCF Ratio | 6.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.34, with an EV/FCF ratio of 11.83.
| EV / Earnings | -34.78 |
| EV / Sales | 1.18 |
| EV / EBITDA | 12.34 |
| EV / EBIT | 140.11 |
| EV / FCF | 11.83 |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 140.06.
| Current Ratio | 2.08 |
| Quick Ratio | 1.13 |
| Debt / Equity | 140.06 |
| Debt / EBITDA | 6.95 |
| Debt / FCF | 6.66 |
| Interest Coverage | 0.19 |
Financial Efficiency
Return on equity (ROE) is -6.84% and return on invested capital (ROIC) is 0.46%.
| Return on Equity (ROE) | -6.84% |
| Return on Assets (ROA) | 0.34% |
| Return on Capital (ROIC) | 0.46% |
| Revenue Per Employee | 692,375 |
| Profits Per Employee | -23,500 |
| Employee Count | 2,400 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.53 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.36% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +10.36% |
| 50-Day Moving Average | 0.91 |
| 200-Day Moving Average | 0.93 |
| Relative Strength Index (RSI) | 48.23 |
| Average Volume (20 Days) | 296,448 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gulf Pharmaceutical Industries P.S.C. had revenue of AED 1.66 billion and -56.40 million in losses. Loss per share was -0.05.
| Revenue | 1.66B |
| Gross Profit | 608.50M |
| Operating Income | 14.00M |
| Pretax Income | -46.70M |
| Net Income | -56.40M |
| EBITDA | 112.50M |
| EBIT | 14.00M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 220.90 million in cash and 1.10 billion in debt, giving a net cash position of -883.20 million or -0.76 per share.
| Cash & Cash Equivalents | 220.90M |
| Total Debt | 1.10B |
| Net Cash | -883.20M |
| Net Cash Per Share | -0.76 |
| Equity (Book Value) | 788.30M |
| Book Value Per Share | 0.67 |
| Working Capital | 855.30M |
Cash Flow
In the last 12 months, operating cash flow was 207.70 million and capital expenditures -41.90 million, giving a free cash flow of 165.80 million.
| Operating Cash Flow | 207.70M |
| Capital Expenditures | -41.90M |
| Free Cash Flow | 165.80M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 36.62%, with operating and profit margins of 0.84% and -3.39%.
| Gross Margin | 36.62% |
| Operating Margin | 0.84% |
| Pretax Margin | -2.81% |
| Profit Margin | -3.39% |
| EBITDA Margin | 6.77% |
| EBIT Margin | 0.84% |
| FCF Margin | 9.98% |
Dividends & Yields
Gulf Pharmaceutical Industries P.S.C. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -5.30% |
| FCF Yield | 15.58% |
Stock Splits
The last stock split was on May 28, 2020. It was a reverse split with a ratio of 0.5655820688.
| Last Split Date | May 28, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.5655820688 |